This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Efficacy and safety of saline nasal irrigation plus theophylline for treatment of COVID-19–related olfactory dysfunction. The SCENT2 Phase 2 Randomized Clinical Trial.
JAMA Otolaryngology Head and Neck Surgery:2022: July 7 Full text
Health service COVID-19 wellbeing and support initiatives: a mixed-methods evaluation. AUS
Occupational Medicine:2022: July 1 Full text
Hospitalization outcomes among patients with COVID-19 undergoing remote monitoring.
JAMA Network Open:2022: July 7 Full text
Risk factors for admission within a hospital-based COVID-19 home monitoring program.
Open Forum Infectious Diseases:2022: June 4 Full text
Brain imaging and neuropsychological assessment of individuals recovered from mild to moderate SARS-CoV-2 infection.
MedRxiv:2022: July 9 Full text
Association between COVID-19 restrictions and emergency department presentations for paediatric mental health in Victoria, Australia. AUS
Australian Health Review:2022: July 5 Full text
Pathophysiology, Epidemiology and Long Covid
Outcomes of SARS-CoV-2 reinfection.
Research Square:2022: June 17 Full text
Long COVID-19 liver manifestation in children.
Journal of Pediatric Gastroenterology and Nutrition:2022: June 10 Full text
Association Between BNT162b2 vaccination and Long COVID after infections not requiring hospitalization in health care workers.
JAMA:2022: July 2 Full text
Prevalence of and factors associated with post-COVID-19 condition in the 12 months following the diagnosis of COVID-19 in adults followed in general practices in Germany.
Open Forum Infectious Diseases:2022: July 4 Full text
SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes.
PNAS Nexus:2022: July 4 Full text
Delivering pandemic vaccines in 100 days — what will it take?
New England Journal of Medicine:2022: July 14 Full text
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.
MedRxiv:2022: July 10 Full text
Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade.
eBioMedicine:2022; July 9 Full text